Please login to the form below

Not currently logged in
Email:
Password:

Daiichi Sankyo promotes Dr Marielle Cohard-Radice

She becomes executive vice president, global head of development

Daiichi Sankyo Dr Marielle Cohard-RadiceDaiichi Sankyo has promoted Dr Marielle Cohard-Radice to executive vice president, global head of development.

Based out of the pharmaceutical firm's Edison, New Jersey office, Dr Marielle Cohard-Radice will take on responsibility for the development strategy and portfolio planning for the cardiovascular-metabolism and internal medicine therapeutic areas.

Dr Cohard-Radice most recently served as vice president of clinical development operation for Daiichi Sankyo's Pharma Development business, as well as serving as the company's managing director for European development.

Prior to joining Daiichi Sankyo in 2012, Dr Cohard-Radice held senior leadership positions at Axcan Pharma, Novartis, Merck & Co and Schering-Plough Research Institute.

Dr Glenn Gormley, senior executive officer and global head, research and development at Daiichi Sankyo, said: “Dr Cohard-Radice brings more than 25 years of experience and success in the global development of medicines.

“Marielle is a proven leader who simultaneously drives accountability and collaboration across global teams, always with a keen focus on the needs of patients.”

Meanwhile, Dr Cohard-Radice's predecessor Dr Mahmoud Ghazzi, the former global head of development, has left the company.

Dr Gormley added: “Dr Ghazzi's contributions at Daiichi Sankyo are most appreciated and we wish him all the best in his new endeavours.”

7th September 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Fendix is the only NHS digital media network and it provides organisations, such as pharma, with unrivalled digital access to...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics